Related Experiment Video
Updated: Nov 23, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
The influence of pre-existing hypertension on coronavirus disease 2019 patients
Zhi-Yao Wei1, Rui Qiao2, Jian Chen3
1Department of Cardiology, Center for Coronary Heart Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Patients with hypertension experienced more severe Coronavirus disease 2019 (COVID-19) outcomes. This underlying condition increases the risk of severe illness, regardless of other factors, highlighting the need for focused care.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Hypertension is a prevalent comorbidity among Coronavirus disease 2019 (COVID-19) patients.
- Understanding the impact of pre-existing conditions on COVID-19 severity is crucial for patient management.
Purpose of the Study:
- To investigate whether hypertension is a risk factor for severe illness in hospitalized COVID-19 patients.
- To assess the association between hypertension and COVID-19 severity, adjusting for potential confounders.
Main Methods:
- A multi-center, retrospective cohort study.
- Inclusion of 498 hospitalized patients with lab-confirmed COVID-19 in China.
- Logistic regression analysis to determine the association between hypertension and severe COVID-19.
Main Results:
- Over 16% of COVID-19 patients had pre-existing hypertension.
- Hypertensive patients had a significantly higher incidence of severe COVID-19 (21% vs. 10%, P = 0.007).
- The increased risk of severe illness associated with hypertension was independent of age, sex, and admission blood pressure.
Conclusions:
- Hypertension is a significant risk factor for severe illness in COVID-19 patients.
- COVID-19 patients with hypertension require heightened clinical attention due to increased susceptibility to severe outcomes and cardiac complications.
- Early identification and management of hypertension in COVID-19 patients are essential for improving prognosis.
Abstract:
Hypertension represents one of the most common pre-existing conditions and comorbidities in Coronavirus disease 2019 (COVID-19) patients. To explore whether hypertension serves as a risk factor for disease severity, a multi-centre, retrospective study was conducted in COVID-19 patients. A total of 498 consecutively hospitalised patients with lab-confirmed COVID-19 in China were enrolled in this cohort. Using logistic regression, we assessed the association between hypertension and the likelihood of severe illness with adjustment for confounders. We observed that more than 16% of the enrolled patients exhibited pre-existing hypertension on admission. More severe COVID-19 cases occurred in individuals with hypertension than those without hypertension (21% vs. 10%, P = 0.007). Hypertension associated with the increased risk of severe illness, which was not modified by other demographic factors, such as age, sex, hospital geological location and blood pressure levels on admission. More attention and treatment should be offered to patients with underlying hypertension, who usually are older, have more comorbidities and more susceptible to cardiac complications.
Related Concept Videos
Hypertension II: Pathophysiology
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management

